These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34905534)

  • 21. TBE booster immunization in adults--first experience with a new tick-borne encephalitis (TBE) vaccine, free of protein-derived stabilizer.
    Zent O; Schwarz TF; Plentz A; Banzhoff A; Jilg W
    Int J Med Microbiol; 2004 Apr; 293 Suppl 37():134-8. PubMed ID: 15146995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody persistence after two vaccinations with either FSME-IMMUN® Junior or ENCEPUR® Children followed by third vaccination with FSME-IMMUN® Junior.
    Prymula R; Pöllabauer EM; Pavlova BG; Löw-Baselli A; Fritsch S; Angermayr R; Geisberger A; Barrett PN; Ehrlich HJ
    Hum Vaccin Immunother; 2012 Jun; 8(6):736-42. PubMed ID: 22699436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seropersistence of tick-borne encephalitis antibodies, safety and booster response to FSME-IMMUN 0.5 ml in adults aged 18-67 years.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Koska M; Bobrovsky R; Konior R; Ehrlich HJ
    Hum Vaccin; 2009 Aug; 5(8):551-6. PubMed ID: 19430202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term persistence of tick-borne encephalitis antibodies in adults 5 years after booster vaccination with Encepur Adults.
    Plentz A; Jilg W; Schwarz TF; Kuhr HB; Zent O
    Vaccine; 2009 Feb; 27(6):853-6. PubMed ID: 19071180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for a 10-year TBE vaccine booster interval: an evaluation of current data.
    Schelling J; Einmahl S; Torgler R; Larsen CS
    Expert Rev Vaccines; 2024; 23(1):226-236. PubMed ID: 38288983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tick-borne encephalitis (TBE) in Switzerland: does the prolongation of vaccine booster intervals result in an increased risk of breakthroughs?
    Schmidt AJ; Altpeter E; Graf S; Steffen R
    J Travel Med; 2022 Mar; 29(2):. PubMed ID: 34581402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule.
    Zent O; Jilg W; Plentz A; Schwarz TF; Frühwein N; Kuhr HB; Banzhoff A
    Vaccine; 2003 Dec; 21(32):4655-60. PubMed ID: 14585672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of tick-borne encephalitis by FSME-IMMUN vaccines: review of a clinical development programme.
    Loew-Baselli A; Poellabauer EM; Pavlova BG; Fritsch S; Firth C; Petermann R; Barrett PN; Ehrlich HJ
    Vaccine; 2011 Oct; 29(43):7307-19. PubMed ID: 21843576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to tick-borne encephalitis (TBE) booster vaccination after prolonged time intervals to primary immunization with the rapid schedule.
    Schöndorf I; Schönfeld C; Nicolay U; Zent O; Banzhoff A
    Int J Med Microbiol; 2006 May; 296 Suppl 40():208-12. PubMed ID: 16531118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, phase II dose-finding studies of a modified tick-borne encephalitis vaccine: evaluation of safety and immunogenicity.
    Ehrlich HJ; Pavlova BG; Fritsch S; Poellabauer EM; Loew-Baselli A; Obermann-Slupetzky O; Maritsch F; Cil I; Dorner F; Barrett PN
    Vaccine; 2003 Dec; 22(2):217-23. PubMed ID: 14615149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementation of preventive measures against tick-borne infections in a non-endemic area for tick-borne encephalitis-Results from a population-based survey in Lower Saxony, Germany.
    Caputo M; Stumpe V; Rübsamen N; Mikolajczyk RT; Karch A
    Ticks Tick Borne Dis; 2019 Apr; 10(3):614-620. PubMed ID: 30797728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules.
    Costantini M; Callegaro A; Beran J; Berlaimont V; Galgani I
    Hum Vaccin Immunother; 2020 Sep; 16(9):2274-2279. PubMed ID: 31951780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seropersistence and booster response following vaccination with FSME-IMMUN in children, adolescents, and young adults.
    Poellabauer E; Angermayr R; Behre U; Zhang P; Harper L; Schmitt HJ; Erber W
    Vaccine; 2019 May; 37(24):3241-3250. PubMed ID: 30928173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized phase II study of a new tick-borne encephalitis vaccine using three different doses and two immunization regimens.
    Harabacz I; Bock H; Jüngst C; Klockmann U; Praus M; Weber R
    Vaccine; 1992; 10(3):145-50. PubMed ID: 1557929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
    Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
    Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies.
    Loew-Baselli A; Konior R; Pavlova BG; Fritsch S; Poellabauer E; Maritsch F; Harmacek P; Krammer M; Barrett PN; Ehrlich HJ;
    Vaccine; 2006 Jun; 24(24):5256-63. PubMed ID: 16624457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and safety of the tick-borne encephalitis vaccination (2009-2019): A systematic review.
    Rampa JE; Askling HH; Lang P; Zens KD; Gültekin N; Stanga Z; Schlagenhauf P
    Travel Med Infect Dis; 2020; 37():101876. PubMed ID: 32931931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21).
    Schoendorf I; Ternak G; Oroszlàn G; Nicolay U; Banzhoff A; Zent O
    Hum Vaccin; 2007; 3(2):42-7. PubMed ID: 17297298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TBE booster immunization according to the rapid immunization schedule: are 3-year booster intervals really necessary?
    Zent O; Plentz A; Schwarz TF; Frühwein N; Kuhr HB; Broeker M; Banzhoff A; Jilg W
    Vaccine; 2004 Dec; 23(3):312-5. PubMed ID: 15530673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistence of immunity to tick-borne encephalitis after vaccination and natural infection.
    Baldovin T; Mel R; Bertoncello C; Carpenè G; Soppelsa F; Giliberti A; Baldo V
    J Med Virol; 2012 Aug; 84(8):1274-8. PubMed ID: 22711356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.